Antiretroviral Therapy and Viral Suppression Among Active Duty Service Members with Incident HIV Infection — United States, January 2012–June 2018
- 3 April 2020
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report (MMWR)
- Vol. 69 (13), 366-370
- https://doi.org/10.15585/mmwr.mm6913a2
Abstract
The Department of Defense model of human immunodeficiency virus care demonstrates that the goals of high antiretroviral therapy uptake and viral suppression can be achieved and maintained in a large health care system.This publication has 6 references indexed in Scilit:
- Vital Signs:HIV Transmission Along the Continuum of Care — United States, 2016Morbidity and Mortality Weekly Report (MMWR), 2019
- Durations of military service after diagnoses of HIV-1 infections among active component members of the U.S. Armed Forces, 1990-2013.2015
- Virologic suppression among HIV-infected US Air Force members in a highly-structured programme with free access to careInternational Journal of STD & AIDS, 2014
- Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History StudyAIDS Research and Therapy, 2010
- Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort studyAIDS, 2009
- The Defense Medical Surveillance System and the Department of Defense Serum Repository: Glimpses of the Future of Public Health SurveillanceAmerican Journal of Public Health, 2002